About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, July 25th, 2017

The QualityStocks
Daily Stock List


nFüsz, Inc. (FUSZ)

InvestorsHub and MarketWatch reported on nFüsz, Inc. (FUSZ), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

nFüsz, Inc. (previously bBooth) is a digital technology enterprise headquartered in Hollywood, California. The Company’s proprietary next generation interactive video technology is the nucleus of its new broadcast and cloud-based, Software-as-a-Service (SaaS) products. Its service is built around its proprietary 'Video-First' Notifi technology. This technology places interactive video front and center in all customer and prospect communications. nFüsz’s shares trade on the OTCQB.

nFüsz offers subscription-based Customer Relationship Management (CRM), sales lead generation, and social engagement software on mobile and desktop platforms. These are for sales-based organizations, consumer brands, and artists looking for greater levels of engagement and higher conversion rates.

The Company’s software platform can accommodate any size campaign or sales organization. Additionally, it is enterprise-class scalable to meet the needs of today's worldwide organizations.

nFüsz products include notifiWEB. This product enables customers to create and display sales, product, or corporate videos with ‘clickable’ interactive links in the actual video on their ‘WordPress’ and other template-based websites, viewable on desktop and mobile devices.

The Company also has its notifiADS product. NotifiADS permits its customers to embed their interactive videos in online ads they can place almost anywhere online.

notifiCRM is nFüsz’s flagship product. notifiCRM is a cloud-based SaaS product. It is offered on a subscription basis, as a fully branded white labeled desktop, mobile, and web-based application (or embedded in customers’ existing applications through an API). The Company built an enterprise-class, fully scalable platform around its core technology for the creation and delivery of interactive videos as the centerpiece of a CRM and Lead Generation solution for any sales-based organization.

Furthermore, nFüsz has its notifiLINKS product. With it, customers can take that same interactive video described in the above-mentioned products, with all the interactive elements intact and distribute to them by way of Email; Text Messaging; Social Media; Electronic Invitations, and more.

In June, nFüsz announced that it entered into an agreement to provide interactive video auctions for uBid.com. For 17 years, uBid.com has been the recognized go-to online auction marketplace for new, overstock, closeout, and also re-certified products in over 25 categories. These categories include Electronics, Collectibles, Jewelry, and Travel.

Also, in June, nFüsz announced that it entered into an agreement with ScoutsView Sports to provide interactive video profiles to match talented athletes with coaches, scouts, and fans. With a ScoutsView Sports subscription, scouts, agents, coaches, and fans can view the profiles, videos, and statistics of athletic talent prospects in the U.S. and internationally.

Last week, nFüsz announced that it entered into an agreement to license its Notifi interactive video technology platform to DealYah. DealYah is a new online marketplace where businesses can advertise their discounted products or services to a broad variety of consumers. DealYah users have free access to built-in marketing tools. This includes nFüsz 's interactive video technology that allows business owners to create, modify, monitor, and publish deals within minutes.

nFüsz, Inc. (FUSZ), closed Tuesday's trading session at $0.12, down 19.46%, on 71,900 volume with 13 trades. The average volume for the last 60 days is 120,292 and the stock's 52-week low/high is $0.05/$0.51.

NXT Energy Solutions, Inc. (NSFDF)

StockOoodles, Streetwise Reports, SmarTrend Newsletters, Vantage Wire, and Serious Traders reported previously on NXT Energy Solutions, Inc. (NSFDF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

NXT Energy Solutions, Inc. is a technology company based in Calgary, Alberta. Its proprietary Stress Field Detection (SFD®) survey system utilizes quantum-scale sensors to detect gravity field perturbations in an airborne survey method, which can be used onshore and offshore to remotely identify areas with exploration potential for traps and reservoirs. Established in 1994, NXT Energy Solutions lists on the OTC Markets Group’s OTCQB.

The Company’s objective this year is to apply its next generation of sensor design to further demonstrate SFD's® technical capabilities in large-scale oil and gas exploration programs globally. NXT serves customers by way of direct sales methods and commissioned sales representatives, primarily in North America. It provides its clients with an effective and reliable method to reduce time, costs, and also risks related to exploration.

NXT’s SFD® survey system permits its clients to concentrate their hydrocarbon exploration decisions concerning land commitments, data acquisition expenditures, and prospect prioritization on areas with the greatest potential. SFD® is environmentally friendly. It is unaffected by ground security issues or difficult terrain. The Company’s innovative geophysical service is for the upstream oil and gas industry.

SFD® is an airborne tool that provides information on areas favorable to fluid entrapment in the sedimentary column. The SFD® survey is complementary to existing geophysical methods, especially seismic programs. In pre-seismic applications, SFD® can produce high-potential prospect leads in large underexplored regions. In post-seismic applications, SFD® can prioritize seismic prospects based on their reservoir potentials.

In January 2017, NXT Energy Solutions announced the first worldwide patent of the Stress Field Detection (SFD®) Technology and the development of a new generation of sensors, which will enhance the Company’s ability to provide higher quality survey results.

Recently, NXT Energy Solutions announced that it closed a sale and leaseback transaction with a Calgary-based international aircraft service provider (the Lessor), where the Lessor bought NXT's Cessna Citation aircraft for US $2,300,000 (about $2,700,000 $CDN after costs). This aircraft will remain dedicated to NXT over the next 5 years. The transaction was completed and funds received on April 28, 2017.

In addition, NXT Energy Solutions recently announced that it started work on the first ever SFD® Multi-Client Survey in the Gulf of Mexico. The Company’s patented SFD® Technology has been approved by the Comisión Nacional de Hidrocarburos, (CNH), for work credits by exploration companies in Mexico. The airborne survey will be conducted over the areas that have been identified by CNH for the shallow water bid-round 2.1, encompassing the Tampico-Misantla, Veracruz, and Cuencas del Sureste exploration areas.

NXT Energy Solutions, Inc. (NSFDF), closed Tuesday's trading session at $0.71, up 10.16%, on 3,000 volume with 2 trades. The average volume for the last 60 days is 6,437 and the stock's 52-week low/high is $0.49/$1.25.

Protea Biosciences Group, Inc. (PRGB)

SmallCapVoice and INO.com Market Report reported previously on Protea Biosciences Group, Inc. (PRGB), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Protea Biosciences Group, Inc. is a molecular information company headquartered in Morgantown, West Virginia. The Company provides proprietary bio-analytical technology to the pharmaceutical and life science industries. It does so through applying its proprietary technology to identify and characterize the proteins, metabolites, lipids and other biologically-active molecules that are the by-products of all living cells and life forms. Protea Biosciences Group lists on the OTCQB.

Protea centers on meeting the needs of the pharmaceutical, biotechnology, agriculture, chemical, and other industries with unique technologies, software, and services. Its proprietary technology enables direct molecular imaging (the ability to identify and display biomolecules in tissue and cells, without sample pre-treatment). The Company delivers strong molecular information to medical and life science researchers around the globe.

Protea Biosciences is the leader in mass spectrometry imaging services (MSI). Pertaining to MSI Services, its research laboratory brings access to the most advanced and cutting-edge MSI technologies and workflows. Protea maintains its own laboratory facility. At this facility, it performs services using (Laser Ablation Electrospray Ionization) LAESI® and complementary technologies for a wide spectrum of customers to support preclinical pharmaceutical research and development (R&D), biomarker discovery, as well as other applications.

The LAESI DP-1000 is an integrated system that combines LAESI and ProteaPlot™. The Company’s LAESI system is a next generation molecular imaging platform. It directly analyzes biological samples without the need to apply chemicals or introduce tags or tracers. It enables 2-dimensional and 3-dimensional imaging, displaying the distribution of molecules in the samples.

Also, Protea collaborates with researchers to apply its technologies and expertise to generate new discoveries and intellectual property (IP). Its proprietary technology, LAESI®, is used with mass spectrometry to detect the presence of up to, and over, 1,000 distinct molecules from a single analysis of samples, which can include tissues, cells, fluids, agricultural specimens, and other sample kinds. Employing proprietary software, the location of each distinct molecule in a respective sample can be displayed. This enables direct molecular imaging.

In June, Protea Biosciences announced its development of new technology, which enables the direct molecular imaging of the distribution of metabolites and peptides in human clinical tissue samples. Dr. Erin Seeley, Principal Scientist at Protea presented the results at the 65th Annual Meeting of the American Society for Mass Spectrometry and Allied Topics, June 4-8, 2017, held in Indianapolis, Indiana. The results show Protea Biosciences’ ability to attain seamless molecular imaging of both peptides and metabolites in FFPE tissue.

This month, Protea Biosciences announced that it integrated its therapeutic antibody analytical methods with new software developed by its partner, Protein Metrics, to automate the detailed analysis of the antibody's structure. The results were presented at the 65th American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics. Protea Biosciences’ new methods can identify therapeutic antibody deviations and impurities, in the form of host cell proteins, which may occur as part of the recombinant protein production process. 

Protea Biosciences Group, Inc. (PRGB), closed Tuesday's trading session at $0.05, down 1.96%, on 242,512 volume with 13 trades. The average volume for the last 60 days is 81,773 and the stock's 52-week low/high is $0.04/$0.20.

OptimizeRx Corp. (OPRX)

Marketbeat, Streetwise Reports, and Bull in Advantage reported on OptimizeRx Corp. (OPRX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A health technology software company, OptimizeRx Corp. provides innovative consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products. The Company does so while providing pharmaceutical and healthcare companies effective ways to expand awareness, access, and adherence to their medications. OptimizeRx is the leading aggregator of pharmaceutical-sponsored services in electronic health record (EHR) platforms. The Company’s core product is SampleMD. OTCQB-listed, OptimizeRx is based in Rochester, Michigan.
The Company’s SampleMD replaces drug samples with electronic trial vouchers and co-pay coupon savings. These are electronically added to an e-Prescription and sent electronically to the pharmacy and is integrated within leading Electronic Health Record (EHR) platforms in the country. These include Allscripts, DrFirst, NewCrop, Quest Diagnostics, and Practice Fusion, and other EHRs.

OptimizeRx initially launched its SampleMD e-coupon solution in April of 2015 within Practice Fusion's EMR. The Company promotes patients’ savings and support from the world's largest pharmaceutical companies. These include Pfizer, Lilly, Novartis, AstraZeneca, and numerous others.

OptimizeRx also launched its OPTIMZEHR™. This is its consulting and implementation practice to assist pharmaceutical-biotechnology companies and healthcare provider platforms in determining and executing on mutually beneficial opportunities to jointly assist physicians and patients within their EHR workflow.

OptimizeRx has a suite of services that integrate complete brand support into the EHR. This leads to enhanced patient care and improved outcomes. The offerings include Brand Messaging and Brand Support. OptimizeRx’s core product has been financial messaging, providing physicians with electronic coupons, co-pay offers, and vouchers for their patients at the point of care (PoC). The Company’s brand support services include New Product Launch/ Drug File Integration; Sales Training and Support; as well as EHR Strategy and Planning.

Eye Care Leaders (ECL) has integrated with OptimizeRx.  Through a platform integration, ECL and OptimizeRx will provide cost saving and patient information services within EHRs that are part of ECL’s portfolio of performance solutions for greater than 6,800 ophthalmologists and optometrists. ECL is the top provider of practice performance solutions for ophthalmologists and optometrists.

OptimizeRx has partnered with Glenwood Systems, a top healthcare software development enterprise. Glenwood Systems provides software and billing services to ambulatory medical practices, surgical centers, and hospitals, which are designed to improve patient care and patient satisfaction. Glenwood’s EHR lessens healthcare delivery costs, while increasing revenue and profitability via an integration with existing patient management systems. OptimizeRx services will operate seamlessly within Glenwood’s EHR, and alert health care providers (HCPs) to potential prescription savings and support information for patients.

OptimizeRx will hold a conference call on Tuesday, August 1, 2017 at 4:30 p.m. Eastern Time to discuss results for Q2 ended June 30, 2017. OptimizeRx management will host the presentation, followed by a question and answer period.

OptimizeRx Corp. (OPRX), closed Tuesday's trading session at $1.06, down 3.64%, on 11,100 volume with 2 trades. The average volume for the last 60 days is 26,041 and the stock's 52-week low/high is $0.63/$1.19.

Aspen Group, Inc. (ASPU)

TaglichBrothers, Stock News Now, TheMicrocapNews, Greenbackers, and RedChip reported on Aspen Group, Inc. (ASPU), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Aspen Group, Inc. is a nationally accredited online post-secondary education company (Aspen University). The mission of Aspen University is to offer any motivated college-worthy student the opportunity to receive a high quality, responsibly priced distance-learning education to realize sustainable economic and social benefits for themselves and their families. Aspen Group has its headquarters in Denver, Colorado. The Company’s shares trade on the OTC Markets’ OTCQB.

Aspen University’s commitment is to provide the highest quality education experiences taught by top-tier faculty. Fifty-six percent of Aspen University’s adjunct faculty hold doctoral degrees.

Degrees offered by Aspen University include Associates, Bachelor’s, Master’s, Doctoral, and Certificates. Aspen University has its School of Professional Studies, School of Nursing, School of Education, School of Management, School of Information Technology, and College of Arts and Sciences.

Recently, Aspen Group announced that it entered into a definitive agreement to acquire United States University, for a total purchase price of $9 million. United States University is a regionally accredited for-profit university based in San Diego, California. Aspen Group’s intention is to continue operating United States University as an independent, for-profit university governed by its own Board of Trustees. Therefore, Aspen Group has no intention in the future to merge United States University and Aspen University.

Last month, Aspen Group announced that Dr. Cheri St. Arnauld was promoted to oversee the academic operations of the parent company. Since March 2014, as the Chief Academic Officer of Aspen University, Inc., Aspen Group’s wholly-owned subsidiary, Dr. St. Arnauld increased educational offerings, attained programmatic and university re-accreditation, and established online processes and resources to support one of the fastest growing online educational institutions in the nation.

In addition, Aspen Group announced the appointment of Dr. Kevin Thrasher to the Provost position of Aspen University, reporting to Dr. St. Arnauld. Since joining Aspen in early 2016, Dr. Thrasher has held the positions of Senior Vice President of Academic Affairs and Dean, School of Education.

Earlier this month, Aspen Group announced Aspen University’s launch of the Doctor of Nursing Practice (DNP) in Leadership online degree program. The design of the DNP degree is to be a practice-focused program, which combines a scholarly approach to the discipline of nursing. The program prepares advanced practice nurses and educators to lead their organizations and the next generation of nurses.

Aspen Group, Inc. (ASPU), closed Tuesday's trading session at $7.02, up 0.29%, on 43,142 volume with 59 trades. The average volume for the last 60 days is 50,236 and the stock's 52-week low/high is $0.12/$2.75.


The QualityStocks
Company Corner


ORHub, Inc. (ORHB)

The QualityStocks Daily Newsletter would like to spotlight ORHub, Inc. (ORHB). Today, ORHub, Inc. closed trading at $0.63, up 5.00%, on 65,532 volume with 27 trades. The stock’s average daily volume over the past 60 days is 35,027 and its 52-week low/high is $0.05/$2.09.

ORHub, Inc. today announces the launch of its fourth service line, marking the company's strategically planned entry point into neurosurgery. ORHub continues to innovate at the speed of customer demand in the health care industry. By providing transformative medical software to this segment of the nation's health care industry, ORHub exponentially grows its addressable market of hospitals and ambulatory surgical centers, which collectively perform over 100 million procedures each year. This new service line also expands the company's portfolio of service lines to four: Spinal, Hip & Knee, Cardiac & Cardiology, and Neurosurgery.

ORHub, Inc. (ORHB) is a cloud-based software platform designed to transform the business of surgery into a value-based model. The platform empowers care providers at every stage of the surgical process to collaborate, organize, deliver, measure, and reimburse in one intuitive, easy-to-use program. This significantly decreases cost and improves outcomes by eliminating inefficiencies, duplications of effort, and errors and omissions that result from siloed processes in outdated software and poor handoffs from one part of the care process to another.

The need for ORHub is clear. Health care costs are out of control at more than 17% of US GDP, which equates to over $3 trillion per year. With costs rising every year due to an aging population and increasingly expensive treatments, providers are under severe pressure to become more efficient and reduce costs. This is happening because payors are aggressively reducing reimbursements and finally moving away from fee-for-service and toward a performance-based reimbursement system referred to as value-based health care.

Accurately measuring the cost of treating a condition and relating that cost to the patient's outcome is at the heart of value-based health care. Institutions that have adopted this model have reaped savings of 20-40% on their overall cost of care. Unfortunately, today's siloed IT systems are fundamentally at odds with this process. Legacy health care solutions come from a fee-for-service world and have reinforced the problem and produced a system with erratic quality and unsustainable costs. Most health care applications today are incremental improvements on these existing systems or are simple digital implementations of antiquated pen-and-paper processes.

Providers wanting to practice value-based health care need value-based software. ORHub creates a value-based solution that will revolutionize surgical care delivery by tracking the cost of treating a condition from diagnosis to discharge, and tracking outcomes that resulted from that treatment.

In an industry where major IT rollouts traditionally cost millions of dollars and take an average of eighteen months, pilot installations of ORHub have been completed in less than a month. By avoiding integration with legacy systems completely through a radically comprehensive and collaborative approach, providers see results right away. This approach produces real-time metrics in a uniform manner at any institution, which makes it ideal for large providers looking to make improvements across the board at multiple facilities.

ORHub started as a pilot program developed in cooperation with a major Southern California hospital. It has since expanded operations into a second facility at the number two non-profit hospital system in the US. Three additional pilot programs are scheduled prior to a national launch. The company has raised more than $1.6 million as of January 2017.

The company is also a showcase member of the startup program at Microsoft, which has been a key partner by providing financial assistance, strategy, introductions to influencers and mentors, and access to its sales organization who see ORHub as an exciting partner to expand the utilization of Microsoft Surface devices and Azure Cloud. Microsoft is funding a major case study in partnership with Intel about the impact of ORHub on participating institutions to be concluded sometime in Q2 2017.

ORHub's leadership team is helmed by Colt Melby, who was appointed CEO in 2016 and has been crucial to developing and executing the company's business strategy. Mr. Melby's extensive business experience includes the NASDAQ uplisting of Smith and Wesson (now American Outdoor Brands), CUI Global Inc., and Quest Resource Holdings Corp. His wealth of information and relationships have been vital in helping the company go from concept to production in institutional medicine in less than a year.

Delivering surgical care to a single patient is a complex process that may take half a dozen companies and more than a dozen departments cooperating inside and outside the care facility. ORHub simplifies and streamlines this process by enabling vendors, providers, and surgeons to collaborate on providing care. Disclaimer

ORHub, Inc. Blog

ORHub, Inc. News:

ORHub, Inc. Introduces Fourth Medical Software Service Line, Continuing Rapid Expansion Strategy

ORHub, Inc. Executing Aggressive Expansion Strategy with Introduction of Third Service Line

ORHub, Inc. Signs National Deployment Agreement to Roll-out Transformative Medical Software in Major U.S. Markets

ChineseInvestors.com, Inc. (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com, Inc. (CIIX). Today, ChineseInvestors.com, Inc. closed trading at $0.949, off by 0.11%, on 43,142 volume with 59 trades. The stock’s average daily volume over the past 60 days is 50,236 and its 52-week low/high is $0.12/$2.75.

SmallCapVoice.com, Inc. and ChineseInvestors.com (OTCQB:CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors in both the U.S. and China, and a well-known cannabidiol (CBD) health brand engaged in the development, manufacturing, marketing and distribution of consumer products containing CBD, today announce that the Company’s director of investor relations, Alan Klitenic, is featured in an audio interview at SmallCapVoice.com. The interview outlining CIIX’s current news and efforts can be heard at http://smallcapvoice.com/blog/7-21-17-smallcapvoice-interview-with-chineseinvestors-com-inc-ciix.

Founded in 1999, ChineseInvestors.com, Inc. (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com, Inc. Blog

ChineseInvestors.com, Inc. News:

ChineseInvestors.com Featured in New Interview with SmallCapVoice.com

ChineseInvestors.com, Inc.'s Subsidiary Files Record of its First Hemp-Infused Skin Care Line With China FDA

NetworkNewsWire Announces Publication Discussing a Variety of Cannabis Investment Options

Algae Dynamics Corp. (ADYNF)

The QualityStocks Daily Newsletter would like to spotlight Algae Dynamics Corp. (ADYNF). Today, Algae Dynamics Corp. closed trading at $0.09, up 76.47%, on 50,000 volume with 5 trades. The stock’s average daily volume over the past 60 days is 7,061 and its 52-week low/high is $0.0001/$0.62.

Algae Dynamics Corp. (ADYNF) is focused on developing proprietary research and products involving botanical oils derived from cannabis and algae.

The original core of the company's product development strategy was the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA to create various nutraceutical products. As a result of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, Algae Dynamics developed a strategy aimed at developing products that combined the health benefits of algae and cannabis oils. Capitalizing on the burgeoning demand for cannabis oil and other smoke-free alternatives to marijuana consumption will help support ongoing initiatives to create and market research-driven product formulations.

Although the company is publicly traded in the U.S., business is conducted in Canada with no exposure to U.S. federal regulation involving cannabis. The Canadian cannabis oil extraction marketplace is projected to grow from C$1 million in 2015 to C$1.7 billion in 2020, which is more than a 1,000-fold increase. With the Government of Canada indicating a target date for full legalization on or before July 2018, numerous opportunities for sales in extracts and oils will open up very soon.

Using Colorado as a comparable example, a study performed by Mackie Research Capital found that 45% of dried marijuana users in the state would eventually convert to marijuana extracts and oils. This is because most consumers taking cannabis for medical purposes are increasingly looking for delivery systems that do not involve smoking marijuana. The market's attractiveness can be further realized when considering that the Canada's licensed producer marketplace is far less competitive with 45 current licensed producers for the whole country vs. 624 licensed cultivators in Colorado.

Collaborating with prominent Canadian universities is a core part of the Algae Dynamics' plan to bolster cannabis extraction expertise, develop premium products and add to its portfolio of intellectual property. Through its agreements with the University of Waterloo and the University of Western Ontario, the company is focusing primarily on the use of extracts from cannabis oil and algae oil in the context of cancer as well as the development of new pharmacotherapies for mental health.

Near-term goals include expanding research and development work with existing and new Canadian universities, securing supply/service agreements with licensed producers, and submitting an application to Health Canada to become a licensed producer of medical marijuana and ultimately have a license to sell products derived from cannabinoids. Algae Dynamics also owns a proprietary technology for the cultivation of low cost, highly pure algae biomass, which will be developed as a vertical integration strategy in the future to support the need to source algae oil for research-driven product formulations. The management team leading these initiatives has nearly a century of beneficial experience spanning from management and process experience to successful fund raising and commercialization.

As part of its key objective to be the #1 research Canadian cannabis oil research-driven product formulator, the company has also formed a strong team of scientific and strategic advisors that complement ongoing R&D relationships and initiatives. Individuals who support the company's initiatives include Dr. Jonathan Blay PhD, FRSB, FIBMS, Csci, CBiol, who performs research and product development on cannabis oil and its constituents in the context of colorectum, pancreas, breast and prostate cancers; and Dr. Steven Laviolette, BSc, PhD, who performs research and product development on cannabis oil and its constituents in the context of depression, post-traumatic stress disorder, anxiety and schizophrenia.

With such a strong foundation laid in the areas being pursued, Algae Dynamics is well positioned to execute on its carefully developed business plan to fast-track to revenue growth while having a longer-term strategy to build a sustainable enterprise-building opportunity in a rapidly expanding market. Disclaimer

Algae Dynamics Corp. Blog

Algae Dynamics Corp. News:

NetworkNewsWire Releases Exclusive Audio Interview with Algae Dynamics Corp. (ADYNF)

Algae Dynamics Corp. (ADYNF) Engages NetworkNewsWire for Corporate Communications Solutions

Algae Dynamics Corp Announces Engagement of Atlanta-Based Broker Dealer Carter, Terry & Company

Kootenay Zinc Corp. (CSE:ZNK) (OTCQB:KTNNF)

The QualityStocks Daily Newsletter would like to spotlight Kootenay Zinc Corp. (KTNNF). Today, Kootenay Zinc Corp. closed trading at $0.067228, up 12.05%, on 71,474 volume with 19 trades. The stock’s average daily volume over the past 60 days is 92,914, and its 52-week low/high is $0.058/$0.59.

Kootenay Zinc Corp. (KTNNF) is a mineral exploration and development company focused on discovering large-scale sedimentary-exhalative ("SEDEX") zinc deposits. Based in Vancouver, British Columbia, the company is ideally positioned near its primary target, the Sully Property, located 18 miles east of the world-class Sullivan Mine.

Of the 22 raw materials tracked by the Bloomberg Commodity Index, zinc was the best-performing base metal in 2016. Based on a widening global supply deficit, outlook for the commodity remains strong. As the most closely tied base metal to the Chinese economy, zinc demand and prices are expected to rise well into the year 2020, putting increased pressure on zinc supply.

For 2017, Goldman Sachs has predicted a 360,000 ton shortage of zinc, along with a subsequent rise in zinc prices to $2,500 per metric ton in the first half of the year. Zinc continues to make history in the metals exchange, driving significant interest in the market amid supply constraints in concentrates and refined metal drive prices.

Ready to claim its share of the market, Kootenay Zinc is focused on its Sully Property. It comprises 1,375 hectares and overlies rocks of similar age and origin as those which host the legendary Sullivan deposit. The Sullivan mine was discovered in 1892, and is known to be one of the world's largest SEDEX deposits. Over its 100-year lifetime, Sullivan produced approximately 150 million tonnes of ore, including approximately 300 million ounces of silver, 8 million tonnes of zinc and 8 million tonnes of lead.

Notably, geophysical data suggests that Kootenay Zinc's Sully project and Sullivan share many geological features:

  • Strata at Sully are in the same sedimentary basin as the Sullivan mine
  • The exact stratigraphic time horizon at which Sullivan formed is present at Sully
  • Filtered AeroMag anomalies coincident with Sullivan Time at Sully appear similar to Sullivan
  • Gravity anomaly at Sully indicates excess mass of comparable magnitude to Sullivan
  • Pb-Zn is present as traces in outcrop, drill core and in a soil geochemical anomaly

The squeeze in zinc supplies particularly affects China, which is both the world's largest zinc consumer and its largest producer, with 4.9 million tons of output in 2015. Chinese manufacturers are now being forced to import zinc for use in cars, household appliances, paints, rubber products and smartphones.

Zinc's rally shows no sign of slowing down in the near future, and companies that currently occupy stake in a zinc deposit find themselves in an enviable position over miners rushing to find new reserves. With its Sully Project, Kootenay Zinc could be on track to capture its share of the market, guided by a management team of mining directors and executives that currently lead some of the world's best mining companies and have been involved in world-class discoveries which sold for billions of dollars. The company's technical team includes industry experts that have worked on mega-mining projects, including the Sullivan and Voisey Bay projects. Disclaimer

Kootenay Zinc Corp. Company Blog

Kootenay Zinc Corp. News:

Sully Project - E3 Target Drilling Underway

Kootenay Zinc Corp.: Sully Project Exploration Update

NetworkNewsWire Releases Exclusive Audio Interview with Kootenay Zinc Corp. (KTNNF)

Lexaria Bioscience Corp. (LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP). Today, Lexaria Bioscience Corp. closed trading at $0.355, up 5.03%, on 22,148 volume with 24 trades. The stock’s average daily volume over the past 60 days is 83,818 and its 52-week low/high is $0.0913/$0.699.

Lexaria Bioscience Corp. (LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body's gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria's products and others on the market is the company's disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the "unusual" taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company's technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria's processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government's National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria's unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience's business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company's patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria's lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world's most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria's revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company's growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets. Disclaimer

Lexaria Bioscience Corp. Blog

Lexaria Bioscience Corp. News:

National Research Council and Lexaria Bioscience Commence Laboratory Work

Lexaria Bioscience Awarded Australian Patent For Cannabinoid Infused Edibles

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is “One to Watch”


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



(ADYNF) +76.47%


(IBIO) +24.24%


(IGC) +24.05%

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251